
Mark Lebwohl
Dean for Clinical Therapeutics · Icahn School of Medicine at Mount Sinai
Credentials: · · · · ·
History

- 1978–1979
Preliminary Internal Medicine
- 1974–1978
Research
Secukinumab in plaque psoriasis--results of two phase 3 trials
New England Journal of Medicine · 2014 · 1,626 citations
The Lancet · 2008 · 1,166 citations
Journal of the American Academy of Dermatology · 2008 · 950 citations

84 papers

75 papers

71 papers
- AB
61 papers

45 papers
- MM
45 papers
- AV
39 papers

37 papers
Grants
- 2012–2016
Phase 2 Study of Magnesium Supplements in the Treatment of PXE
Food and Drug Administration · R01
Contact PI · $916.8K · Icahn School of Medicine at Mount Sinai
- 1997–1998
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $180.2K · Icahn School of Medicine at Mount Sinai
Clinical trials
- 2024–2026
Bimekizumab in Plaque Psoriasis
Principal investigator · Completed · Phase 4
Icahn School of Medicine at Mount Sinai
- 2018
Principal investigator · Completed · Phase 2
Vidac Pharma
- 2017–2018
Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies
Principal investigator · Completed · Phase 4
Icahn School of Medicine at Mount Sinai
- 2017–2019
Principal investigator · Completed · Phase 2
Icahn School of Medicine at Mount Sinai

